Scolaris Content Display Scolaris Content Display

Alpha‐lipoic acid for diabetic peripheral neuropathy

This is not the most recent version

References

Additional references

Ametov 2003

Ametov AS, Barinov A, Dyck PJ, Hermann R, Kozlova N, Litchy WJ, et al. The sensory symptoms of diabetic polyneuropathy are improved with alpha‐lipoic: the SYDNEY trial. Diabetes Care 2003;26(3):770‐6.

Benbow 1998

Benbow SJ, Wallymahmed ME, MacFarlane IA. Diabetic peripheral neuropathy and quality of life. Quarterly Journal of Medicine 1998;91(11):733‐7.

Brownlee 2001

Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414(6865):813‐82.

Collins 2000

Collins SL, Moore RA, McQuay HJ, Wiffen P. Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review. Journal of Pain and Symptom Management 2000;20:449‐58.

Creager 2003

Creager MA, Luscher TF, Cosentino F, Beckman H. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation 2003;108(12):1527‐32.

DCCT 1993

DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long‐term complications in insulin‐dependent diabetes mellitus. New England Journal of Medicine 1993;329(14):977‐86.

Duhmke 2004

Duhmke R, Cornblath D, Hollingshead J. Tramadol for neuropathic pain. Cochrane Database of Systematic Reviews 2004;2:CD003726.

Feldman 2003

Feldman EL. Oxidative stress and diabetic neuropathy: a new understanding of an old problem. Journal of Clinical Investigation 2003;111(4):431‐3.

Fernyhough 2003

Fernyhough P, Huang TJ, Verkhratsky A. Mechanism of mitochondrial dysfunction in diabetic sensory neuropathy. Journal of the Peripheral Nervous System 2003;8(4):227‐35.

Forsblom 1998

Forsblom CM, Sane T, Groop P‐H, Totterman KJ, Kallio M, Saloranta C, et al. Risk factors for mortality in type 2 diabetes: evidence of a role for neuropathy and a protective effect of HLA‐DR4. Diabetologia 1998;41(11):1253‐62.

Gale 2002

Gale EAM, Anderson JV. Diabetes mellitus and other disorders of metabolism. In: Kumar P, Clark M editor(s). Clinical Medicine. London: W. B. Saunders, 2002.

Jacob 1996

Jacob S, Henrikson EJ, Tritschler HJ, Augustin HJ, Dietze GJ. Improvement of insulin stimulated glucose disposal in type 2 diabetes after repeated administration of thioctic acid. Experimental and Clinical Endocrinology & Diabetes 1996;104:284‐8.

Low 1997

Low PA, Nickander KK, Tritscler HJ. The roles of oxidative stress and antioxidant treatment in experimental neuropathy. Diabetes 1997;46(Suppl 2):S38‐S42.

Marchettini 2004

Marchettini P, Teloni L, Formaglio F, Lacerenza M. Pain in diabetic neuropathy case study: whole patient management. European Journal of Neurology 2004;11(Suppl 1):12‐21.

Mason 2004

Mason L, Moore RA, Derry S, Edwards JE, McQuay HJ. Systematic review of topical capsaicin for the treatment of chronic pain. BMJ 2004;328(7446):991.

Meyler 2000

Dukes MNG, Aronson JK, editors. Meyler's Side Effects of Drugs: an encyclopedia of adverse reactions and interactions. 14th Edition. Amsterdam: Elsevier, 2000.

Morikawa 2001

Morikawa T, Yasuno R, Wada H. Do mammalian cells synthesize lipoic acid? Identification of a mouse cDNA encoding a lipoic acid synthase located in mitochondria. FEBS Letters 2001;498(1):16‐21.

Nagamatsu 1995

Nagamatsu M, Nickander KK, Schmelzer JD, Raya A, Wittrock DA, Tritschler H, et al. Lipoic acid improves nerve blood flow, reduces oxidative stress and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 1995;18(8):1160‐7.

Nicolucci 1996

Nicolucci A, Carinci F, Cavaliere D, Scorpiglione N, Belfiglio M, Labbrozi D, et al. A meta‐analysis of trials on aldose reductase inhibitors in diabetic peripheral neuropathy. The Italian Study Group. The St. Vincent Declaration. Diabetes Medicine 1996;13(12):1017‐26.

Oates 2002

Oates PJ. Polyol pathway and diabetic peripheral neuropathy. International Review of Neurobiology 2002;50:325‐92.

Packer 2001

Packer L, Kraemer K, Rimbach G. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 2001;17(10):888‐95.

Pfeifer 1995

Pfeifer MA, Schumer MP. Clinical trials of diabetic neuropathy: past present and future. Diabetes 1995;44(12):1355‐61.

Pirart 1995

Pirart J. Tight glycaemic control prevents diabetic complications. Acta Clinica Belgica 1995;50(6):321‐5.

Snell 1937

Snell EE, Strong FM, Peterson WH. Growth factors for bacteria. VI: Fractionation and properties of an accessory factor for lactic acid bacteria. Biochemistry 1937;31:1789.

Soliman 2002

Soliman E, Gellido C. Diabetic Neuropathy. eMedicine.com March 29, 2002.

Sugimoto 2000

Sugimoto K, Murakawa Y, Sima AA. Diabetic neuropathy ‐ a continuing enigma. Diabetes Metabolism Research and Reviews 2000;16(6):408‐33.

Tomlinson 1992

Tomlinson DR, Willars GB, Carrington AL. Aldose reductase inhibitors and diabetic complications. Pharmacology & Therapeutics 1992;54(2):151‐94.

van Dam 2002

van Dam PS. Oxidative stress and diabetic neuropathy:pathophysiological mechanisms and treatment. Diabetes Metabolism Research Reviews 2002;18(3):176‐84.

WHO 1999

WHO Diagnosis and Classification of Diabetes Mellitus. WHO Department of Noncommunicable Disease Surveillance1999.

Wild 2001

Wild S, Roglic G, Sicree R, Green A, King H. Global burden of diabetes mellitus in the year 2000. The World Health Report 2001. World Health Organization, 2001.

Young 1993

Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993;36(2):150‐4.

Ziegler 1999

Ziegler D, Reljanovic D, Mehnert H, Gries FA. Alpha‐Lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials. Experimental & Clinical Endocrinolgy & Diabetes 1999;107(7):421‐30.

Ziegler 2004

Ziegler D, Nowak H, Kempler P, Vargha P, Low PA. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha‐lipoic acid: a meta‐analysis. Diabetes Medicine 2004;21(2):114‐21.